Parameter | Reference | Study characteristics | Association | OR (95% CI) | P value |
---|---|---|---|---|---|
Histological prostatic inflammation | [17] | Phase II study on prostate biopsies | Inflammation and high grade PC | 2.24 (1.06–4.71) | <0.01 |
Histological prostatic inflammation | [17] | Prostate cancer prevention trial on prostate biopsy | Inflammation and high grade (Gleason score 7–10) PC | 2.24 (1.06–4.71) | <0.01 |
Serum NLR | [26] | metanalysis | NLR and high grade PC | – | 0.573 |
Serum SNP | [41] | Phase II study | IL-8 and high grade PC | 3.5 (1.13–10.88) | <0.01 |
Serum SNP | [41] | Phase II study | IL-1B and IL-10 | 3.38 (1.70–6.71) | <0.01 |